Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRDL Cardiol Therapeutics	$1.66 -0.6%	$1.64	$0.52 ▼ $2.17	$113.16M	0.95	353,445 shs	31,214 shs
KHRN Khiron Life Sciences	C$0.04	C$0.04	C$0.04 ▼ C$0.21	C$9.30M	2.64	256,268 shs	24,000 shs
LABS MediPharm Labs	C$0.08 -6.3%	C$0.07	C$0.06 ▼ C$0.10	C$30.10M	1.04	228,400 shs	2,329 shs
WLLW Willow Biosciences	C$0.09	C$0.10	C$0.06 ▼ C$0.18	C$11.18M	1.11	66,882 shs	10,000 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRDL Cardiol Therapeutics	-4.57%	-14.80%	+9.87%	+56.07%	+217.07%
KHRN Khiron Life Sciences	0.00%	0.00%	0.00%	0.00%	0.00%
LABS MediPharm Labs	-6.25%	-11.76%	+7.14%	+15.38%	-11.76%
WLLW Willow Biosciences	+5.88%	0.00%	-10.00%	-18.18%	-37.93%

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRDL Cardiol Therapeutics	1.2494 of 5 stars	3.5	3.0	0.0	0.0	1.1	0.0	0.6
KHRN Khiron Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LABS MediPharm Labs	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WLLW Willow Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRDL Cardiol Therapeutics	3.00	Buy	$3.00	80.72% Upside
KHRN Khiron Life Sciences	N/A	N/A	N/A	N/A
LABS MediPharm Labs	N/A	N/A	N/A	N/A
WLLW Willow Biosciences	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRDL Cardiol Therapeutics	$60K	1,886.04	N/A	N/A	$0.32 per share	5.19
KHRN Khiron Life Sciences	C$16.14M	0.58	C$0.01 per share	6.67	C$0.12 per share	0.33
LABS MediPharm Labs	C$33.06M	0.91	C$0.06 per share	1.30	C$0.18 per share	0.42
WLLW Willow Biosciences	C$1.59M	7.03	C$0.11 per share	0.83	C$0.05 per share	1.80

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRDL Cardiol Therapeutics	-$20.84M	-$0.33	N/A	N/A	N/A	N/A	-76.18%	-62.52%	5/20/2024 (Estimated)
KHRN Khiron Life Sciences	-C$30.66M	-C$0.17	N/A	∞	N/A	-190.00%	-74.68%	-20.79%	N/A
LABS MediPharm Labs	-C$13.08M	-C$0.05	N/A	∞	N/A	-39.57%	-24.00%	-17.63%	N/A
WLLW Willow Biosciences	-C$15.31M	-C$0.13	N/A	∞	N/A	N/A	-114.91%	-64.02%	5/6/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	N/A
KHRN Khiron Life Sciences	N/A	N/A	N/A	N/A	N/A
LABS MediPharm Labs	N/A	N/A	N/A	N/A	N/A
WLLW Willow Biosciences	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRDL Cardiol Therapeutics	0.01	4.36	4.36
KHRN Khiron Life Sciences	9.46	2.02	0.72
LABS MediPharm Labs	4.33	3.37	3.10
WLLW Willow Biosciences	34.10	3.22	19.71

Ownership

Institutional Ownership

Company	Institutional Ownership
CRDL Cardiol Therapeutics	12.49%
KHRN Khiron Life Sciences	0.22%
LABS MediPharm Labs	0.73%
WLLW Willow Biosciences	0.12%

Insider Ownership

Company	Insider Ownership
CRDL Cardiol Therapeutics	5.25%
KHRN Khiron Life Sciences	4.64%
LABS MediPharm Labs	2.47%
WLLW Willow Biosciences	27.34%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CRDL Cardiol Therapeutics	N/A	68.17 million	64.59 million	Not Optionable
KHRN Khiron Life Sciences	N/A	232.41 million	N/A	Not Optionable
LABS MediPharm Labs	130	401.28 million	N/A	Not Optionable
WLLW Willow Biosciences	32	124.24 million	N/A	Not Optionable

CRDL, LABS, WLLW, and KHRN Headlines

Source	Headline
	TSX:WLLW (Willow Biosciences Inc.) fool.ca - April 18 at 10:49 AM
	Willow Biosciences Inc (WLLW) investing.com - April 10 at 12:57 AM
	Willow Biosciences Full Year 2023 Earnings: CA$0.10 loss per share (vs CA$0.12 loss in FY 2022) finance.yahoo.com - March 31 at 8:21 AM
	Willow Biosciences Inc.: Willow Biosciences Reports Fourth Quarter And Fiscal Year 2023 Financials And Operations And Filing Of Its 2023 Aif finanznachrichten.de - March 29 at 8:21 AM
	Willow Biosciences Inc. (WLLW.TO) sg.finance.yahoo.com - March 6 at 7:12 PM
	Kalsec invests in Willow Biosciences foodbusinessnews.net - February 22 at 2:31 PM
	Willow Biosciences Inc. announces investment from Kalsec canadianmanufacturing.com - February 21 at 2:38 PM
	Willow Biosciences Inc.: Willow Plans For Significant Growth In 2024 On The Back Of A Successful 2023 finanznachrichten.de - January 10 at 12:21 PM
	WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023 finance.yahoo.com - January 10 at 7:18 AM
	Willow Biosciences, Partner Look to Advance Development Program marketwatch.com - December 7 at 8:11 AM
	This Precision-Fermentation Company Achieves Q3 Record Revenue And Strategic Milestones In Business Expansion msn.com - November 15 at 5:55 PM
	Willow Biosciences reduces cash burn, achieves record revenue in 3Q proactiveinvestors.com - November 15 at 12:55 PM
	Willow Biosciences Inc.: Willow Biosciences Reports Third Quarter 2023 Financial Results And Provides Corporate Update finanznachrichten.de - November 15 at 7:55 AM
	Aurora Cannabis settles patent dispute with Willow Biosciences mjbizdaily.com - October 24 at 8:18 PM
	Aurora Cannabis Resolves Patent Litigation With Willow Biosciences nasdaq.com - October 24 at 3:17 PM
	Police Activity Closes Willow Pass Road, Highwy 242 In Concord msn.com - October 11 at 6:46 PM
	Concord police activity shuts down Hwy 242 NB, Willow Pass Rd msn.com - October 11 at 1:46 PM
	Will Smith and Jada Pinkett Smith's kids: All about Jaden, Willow and Trey msn.com - October 10 at 10:56 PM
	WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING finance.yahoo.com - October 10 at 10:56 PM
	Fort Collins Willow apartments sell for $65 million bizwest.com - October 10 at 5:55 PM
	Buffy The Vampire Slayer's Dark Willow Story Was Teased A Whole 4 Years Before It Happened msn.com - October 8 at 5:42 PM
	Visiting Willow Creek, the Northern California town obsessed with Bigfoot sfgate.com - October 8 at 7:41 AM
	Sedan crashes into semi-truck, temporarily closes Willow at Shaw msn.com - October 6 at 11:25 PM
	Willow Bears Fall to 0-7 On The Year ozarkradionews.com - October 6 at 11:25 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
Does Reddit's Successful Public Debut Mean Tech IPOs are Back?
March 22, 2024 6:15 AM
View Does Reddit's Successful Public Debut Mean Tech IPOs are Back?
Planet Labs Soars Fueled by AI Data Demand
April 18, 2024 7:00 AM
View Planet Labs Soars Fueled by AI Data Demand

All Headlines

Company Descriptions

Cardiol Therapeutics

NASDAQ:CRDL

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Khiron Life Sciences

CVE:KHRN

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

MediPharm Labs

TSE:LABS

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Willow Biosciences

TSE:WLLW

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial